Updates are available Correction dated 2019-12-16
Click to view Correction: https://doi.org/10.1186/s40425-019-0830-7
-
Authors
Metzger, Philipp
Kirchleitner, Sabrina V.
Kluge, Michael
Koenig, Lars M.
Hörth, Christine
Rambuscheck, Carlotta A.
Böhmer, Daniel
Ahlfeld, Julia
Kobold, Sebastian
Friedel, Caroline C.
Endres, Stefan
Schnurr, Max
Duewell, Peter https://orcid.org/0000-0003-0836-6448
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (DU1522/1-1, SFB 1123/2 B07, SCHN664/6-1, 329628492 – SFB 1321)
Deutsche Forschungsgemeinschaft (FR2938/7-1)
Elitenetzwerk Bayern (i-Target: Immunotargeting of cancer, i-Target: Immunotargeting of cancer, i-Target: Immunotargeting of cancer)
H2020 Marie Skłodowska-Curie Actions (Training Network for the Immunotherapy of Cancer (IMMUTRAIN), Training Network for the Immunotherapy of Cancer (IMMUTRAIN), Training Network for the Immunotherapy of Cancer (IMMUTRAIN))
- License Information
-
More Information
Article History
Received: 1 April 2019
Accepted: 22 October 2019
First Online: 6 November 2019
Change Date: 16 December 2019
Change Type: Correction
Change Details: Following publication of the original article [1], the authors have reported that Fig. 2 and Additional file 1: Figure S1, S2 partially show red scripts.
Ethics approval and consent to participate
: This study does not include human material. Animal experiments were performed according to ethical guidelines and were approved by the local government, Regierung von Oberbayern, Munich, Germany (55.2–1-54-2532-175-12) .
: Not applicable.
: Parts of this work have been performed for the doctoral theses of P.M. and S.V.K., at the Ludwig-Maximilians-Universität München.
